Table 1.
Demographics
| Demographics | n (%) |
|---|---|
| Total patients | 43 |
| Median age (year) | 74 |
| Gender | |
| Male | 23 (53.5) |
| Female | 20 (46.5) |
| Anticoagulation | |
| Rivaroxaban | 21 (48.8) |
| Apixaban | 22 (51.2) |
| Edoxaban | 0 |
| Indication for anticoagulation | |
| Atrial fibrillation | 30 (69.8) |
| DVT/PE | 9 (20.9) |
| Atrial fibrillation and DVT/PE | 3 (7.0) |
| Lower extremity venous bypass graft | 1 (2.3) |
| Indication for anticoagulation reversal | |
| Gastrointestinal bleeding | 17 (39.5) |
| Intracranial hemorrhage—non-traumatic | 9 (20.9) |
| Intracranial hemorrhage—traumatic | 7 (16.3) |
| Trauma | 5 (14.0) |
| Other | 5 (11.6) |
| Invasive procedure after 4F-PCC administration | 30 (69.8) |
| Gastrointestinal endoscopies | 16 (37.2) |
| Interventional radiology embolization/coiling | 3 (7.0) |
| Craniotomy | 3 (7.0) |
| Orthopedic | 3 (7.0) |
| Other | 5 (11.6) |